Gabriel Yariv
Presidente en CNBX PHARMACEUTICALS INC. .
Perfil
Gabriel Yariv was the founder of Instituto Simutec, founded in 2010, where he held the title of Chief Executive Officer from 2010 to 2017.
He was also the founder of The Yariv Foundation For Leadership Ltd., founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Mr. Yariv's current job(s) include being the Chairman & Chief Operating Officer at CNBX Pharmaceuticals, Inc. since 2019, a Director at TaGeza Biopharmaceuticals Ltd., and a Member at Friends of The Israel Museum Society.
Mr. Yariv's education history includes undergraduate studies at Boston University.
Cargos activos de Gabriel Yariv
| Empresas | Cargo | Inicio |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Presidente | 05/09/2021 |
| Friends of The Israel Museum Society | Corporate Officer/Principal | - |
TaGeza Biopharmaceuticals Ltd.
 TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Gabriel Yariv.
| Empresas | Cargo | Fin |
|---|---|---|
| Instituto Simutec | Fundador | 01/01/2017 |
| The Yariv Foundation For Leadership Ltd. | Director Ejecutivo | 01/01/2009 |
Formación de Gabriel Yariv.
| Boston University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CNBX PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Instituto Simutec | |
| Friends of The Israel Museum Society | |
| The Yariv Foundation For Leadership Ltd. | |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Gabriel Yariv
